INTRODUCTION: The special types of breast cancer seem to have not only distinct morphological features but also distinct biological features. MATERIALS AND METHODS: Women diagnosed with a first primary invasive breast cancer in the 2004-2005 period were identified through Tuscan Cancer Registry. Information on age, tumor size, lymph node status, histological type and grade, hormonal receptors, HER2 immunohistochemical expression were collected. Five subtypes were defined: luminal A, luminal B HER2+, luminal B HER2-, triple negative, and HER2 positive. The association between the histological type and molecular subgroups was assessed by a Fisher's exact test, and a multinomial logistic regression model was used. RESULTS: Out of 1,487 patients, 34 % were luminal A subtype, 25 % luminal B HER2-, 11 % luminal B HER2+, 19 % triple negative, and 10.2 % HER2+; 58.5 % of cancers were ductal NOS types. With luminal A as reference, histological types distribution was significantly different between the subgroups. Mucinous, tubular, and cribriform histotypes were found among luminal A cancers more than in other subgroups; all medullary carcinomas were triple negative cancers. Pathological stage at diagnosis was more advanced, and histological grade was lower among subgroups other than luminal A. CONCLUSIONS: Significant association between breast cancer histotypes and molecular subgroups was found.
INTRODUCTION: The special types of breast cancer seem to have not only distinct morphological features but also distinct biological features. MATERIALS AND METHODS:Women diagnosed with a first primary invasive breast cancer in the 2004-2005 period were identified through Tuscan Cancer Registry. Information on age, tumor size, lymph node status, histological type and grade, hormonal receptors, HER2 immunohistochemical expression were collected. Five subtypes were defined: luminal A, luminal B HER2+, luminal B HER2-, triple negative, and HER2 positive. The association between the histological type and molecular subgroups was assessed by a Fisher's exact test, and a multinomial logistic regression model was used. RESULTS: Out of 1,487 patients, 34 % were luminal A subtype, 25 % luminal B HER2-, 11 % luminal B HER2+, 19 % triple negative, and 10.2 % HER2+; 58.5 % of cancers were ductal NOS types. With luminal A as reference, histological types distribution was significantly different between the subgroups. Mucinous, tubular, and cribriform histotypes were found among luminal A cancers more than in other subgroups; all medullary carcinomas were triple negative cancers. Pathological stage at diagnosis was more advanced, and histological grade was lower among subgroups other than luminal A. CONCLUSIONS: Significant association between breast cancer histotypes and molecular subgroups was found.
Authors: Otto Metzger-Filho; Andrew Tutt; Evandro de Azambuja; Kamal S Saini; Giuseppe Viale; Sherene Loi; Ian Bradbury; Judith M Bliss; Hatem A Azim; Paul Ellis; Angelo Di Leo; José Baselga; Christos Sotiriou; Martine Piccart-Gebhart Journal: J Clin Oncol Date: 2012-03-26 Impact factor: 44.544
Authors: B Weigelt; H M Horlings; B Kreike; M M Hayes; M Hauptmann; L F A Wessels; D de Jong; M J Van de Vijver; L J Van't Veer; J L Peterse Journal: J Pathol Date: 2008-10 Impact factor: 7.996
Authors: Brittany Z Dashevsky; Debra A Goldman; Molly Parsons; Mithat Gönen; Adriana D Corben; Maxine S Jochelson; Clifford A Hudis; Monica Morrow; Gary A Ulaner Journal: Eur J Nucl Med Mol Imaging Date: 2015-05-14 Impact factor: 9.236
Authors: Lindsay A Williams; Hazel B Nichols; Katherine A Hoadley; Chiu Kit Tse; Joseph Geradts; Mary Elizabeth Bell; Charles M Perou; Michael I Love; Andrew F Olshan; Melissa A Troester Journal: Cancer Causes Control Date: 2017-11-09 Impact factor: 2.506
Authors: Canan Kelten Talu; Begum Yeni Erdem; Esra Arslan; Mehmet Ali Nazli; Yasemin Cakir; Didem Can Trabulus Journal: Eur J Breast Health Date: 2022-10-01
Authors: Iain Carmichael; Benjamin C Calhoun; Katherine A Hoadley; Melissa A Troester; Joseph Geradts; Heather D Couture; Linnea Olsson; Charles M Perou; Marc Niethammer; Jan Hannig; J S Marron Journal: Ann Appl Stat Date: 2021-12-21 Impact factor: 1.959
Authors: E Munzone; A Giobbie-Hurder; B A Gusterson; E Mallon; G Viale; B Thürlimann; B Ejlertsen; G MacGrogan; F Bibeau; G Lelkaitis; K N Price; R D Gelber; A S Coates; A Goldhirsch; M Colleoni Journal: Ann Oncol Date: 2015-09-19 Impact factor: 32.976